Leticia De Mattos-Arruda

Leticia De Mattos-Arruda

UNVERIFIED PROFILE

Are you Leticia De Mattos-Arruda?   Register this Author

Register author
Leticia De Mattos-Arruda

Leticia De Mattos-Arruda

Publications by authors named "Leticia De Mattos-Arruda"

Are you Leticia De Mattos-Arruda?   Register this Author

36Publications

1209Reads

50Profile Views

News from ASCO 2018.

Breast Care (Basel) 2018 Aug 12;13(4):298-302. Epub 2018 Jul 12.

University Clinic of Internal Medicine III, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000491564DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167691PMC
August 2018

ESMO Leaders Generation Programme: an alumni insight.

ESMO Open 2018 29;3(1):e000312. Epub 2018 Jan 29.

Department of Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2017-000312DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812397PMC
January 2018

Cancer as an ecomolecular disease and a neoplastic consortium.

Biochim Biophys Acta Rev Cancer 2017 Dec 23;1868(2):484-499. Epub 2017 Sep 23.

Lady Davis Institute, JGH, SMBD, Gerald-Bronfman Department of Oncology, McGill University QC, Montreal H3T 1E2, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0304419X173005
Publisher Site
http://dx.doi.org/10.1016/j.bbcan.2017.09.004DOI Listing
December 2017

Liquid biopsy for HER2-positive breast cancer brain metastasis: the role of the cerebrospinal fluid.

ESMO Open 2017 9;2(4):e000270. Epub 2017 Oct 9.

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2017-000270DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640134PMC
October 2017

Translating neoadjuvant therapy into survival benefits: one size does not fit all.

Nat Rev Clin Oncol 2016 09 22;13(9):566-79. Epub 2016 Mar 22.

Medical Oncology Department, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Paseo Vall d'Hebron 119-129, 08035 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2016.35DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118200PMC
September 2016

Cell-free circulating tumour DNA as a liquid biopsy in breast cancer.

Mol Oncol 2016 Mar 17;10(3):464-74. Epub 2015 Dec 17.

Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK; Department of Oncology, University of Cambridge, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2015.12.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528975PMC
March 2016

BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors.

Melanoma Res 2015 Dec;25(6):486-95

aTranslational Cancer Research Unit, Instituto Oncológico Dr Rosell, Quirón Dexeus University Hospital bPangaea Biotech S.L cHospital Vall d'Hebron dCatalan Institute of Oncology, Hospital Germans Trias i Pujol Badalona eMORe Foundation, Barcelona fHospital Central Asturias, Oviedo gPivotal SL, Madrid hCUN, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000187DOI Listing
December 2015

Escaping out of the brain.

Cancer Discov 2014 Nov;4(11):1259-61

Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-14-1178DOI Listing
November 2014

Pilot studies for personalized cancer medicine: focusing on the patient for treatment selection.

Oncologist 2013 17;18(11):1180-8. Epub 2013 Oct 17.

Molecular Therapies Research Unit, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825301PMC
October 2014

Brain metastasis: new opportunities to tackle therapeutic resistance.

Mol Oncol 2014 Sep 2;8(6):1120-31. Epub 2014 Jun 2.

Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2014.05.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528619PMC
September 2014

Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing.

Mol Oncol 2014 Feb 31;8(1):150-8. Epub 2013 Oct 31.

Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2013.10.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528499PMC
February 2014

Re: time to adjuvant chemotherapy for breast cancer in national comprehensive cancer network institutions.

J Natl Cancer Inst 2013 Dec 11;105(24):1912. Epub 2013 Nov 11.

Affiliations of authors: Department of Oncology, IRCCS Fondazione Istituto Nazionale dei Tumori, Milano, Italy (SDC); Department of Oncology (LdM, JC), and Beast Cancer Surgery (IR), Vall d'Hebron University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt324DOI Listing
December 2013

Clinical response to a lapatinib-based therapy for a Li-Fraumeni syndrome patient with a novel HER2V659E mutation.

Cancer Discov 2013 Nov 15;3(11):1238-44. Epub 2013 Aug 15.

1Vall d'Hebron Institut d'Oncologia; 2Vall d'Hebron Institut de Recerca; 3Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona; 4Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain; and 5Human Oncology & Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0132DOI Listing
November 2013

Circulating tumour cells and cell-free DNA as tools for managing breast cancer.

Nat Rev Clin Oncol 2013 Jul 28;10(7):377-89. Epub 2013 May 28.

Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Paseo Vall d'Hebron 119-129, 08035 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2013.80DOI Listing
July 2013

Use of pertuzumab for the treatment of HER2-positive metastatic breast cancer.

Adv Ther 2013 Jul 24;30(7):645-58. Epub 2013 Jul 24.

Medical Oncology Department, Vall d'Hebron Institute of Oncology, Vall D'Hebron University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-013-0043-2DOI Listing
July 2013

Advances in first-line treatment for patients with HER-2+ metastatic breast cancer.

Oncologist 2012 20;17(5):631-44. Epub 2012 Apr 20.

Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2011-0187DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360903PMC
January 2013

Circulating tumour cells in early breast cancer.

Lancet Oncol 2012 Sep;13(9):e370; author reply e370

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(12)70316-9DOI Listing
September 2012

Breast cancer and HSP90 inhibitors: is there a role beyond the HER2-positive subtype?

Breast 2012 Aug 5;21(4):604-7. Epub 2012 May 5.

Medical Oncology Department, Vall D'Hebron University Hospital, Paseo Vall d'Hebron 119-129, 08035 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2012.04.002DOI Listing
August 2012

Development of molecular biomarkers in individualized treatment of colorectal cancer.

Clin Colorectal Cancer 2011 Dec 12;10(4):279-89. Epub 2011 May 12.

Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2011.03.030DOI Listing
December 2011

Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer.

Future Oncol 2011 Dec;7(12):1385-97

Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.11.122DOI Listing
December 2011

[Evaluation of compliance through specific interviews: a prospective study of 73 children with acute lymphoblastic leukemia].

J Pediatr (Rio J) 2005 May-Jun;81(3):245-50

Departamento de Pediatria, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG.

View Article

Download full-text PDF

Source
January 2006